• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Patients after persistent foramen ovale (PFO) closure: long-term benefits and risks. A contemporary approach to guide clinical decision making
Kardiol Pol. 2021 Feb 17. doi: 10.33963/KP.15817. Online ahead of print.ABSTRACTPatent foramen ovale is a congenital heart disease, which represents 80% of atrial septal defects and consist of a remnant of fetal circulation that functions in post-natal conditions as a transient interatrial right-to-left shunt of variable magnitude. The PFO may be implicated in the pathogenesis of several medical conditions, such as cryptogenic stroke, cryptogenic left circulation thromboembolism, migraine syndromes, decompression sickness. The most frequent indication for PFO closure remains PFO-associated left circulation thromboembolism....
Source: Polish Heart Journal - February 18, 2021 Category: Cardiology Authors: Christian Pristipino Fausta Barbara Filice Source Type: research

Patients after persistent foramen ovale (PFO) closure: long-term benefits and risks. A contemporary approach to guide clinical decision making.
Abstract Patent foramen ovale is a congenital heart disease, which represents 80% of atrial septal defects and consist of a remnant of fetal circulation that functions in post-natal conditions as a transient interatrial right-to-left shunt of variable magnitude. The PFO may be implicated in the pathogenesis of several medical conditions, such as cryptogenic stroke, cryptogenic left circulation thromboembolism, migraine syndromes, decompression sickness. The most frequent indication for PFO closure remains PFO-associated left circulation thromboembolism. In select patients, PFO closure reduces stroke recurrence in ...
Source: Polish Heart Journal - February 17, 2021 Category: Cardiology Authors: Pristipino C, Filice FB Tags: Kardiol Pol Source Type: research

Interventional closure of patent foramen ovale in prevention of thromboembolic events. Consensus document of the Association of Cardiovascular Interventions and the Section of Grown-up Congenital Heart Disease of the Polish Cardiac Society.
Abstract The presence of patent foramen ovale (PFO) was found to be associated with a number of medical conditions, including embolic stroke and recurrent transient neurological defects. The closure of PFO remains controversial, however recently guidelines from European Association of Percutaneous Cardiovascular Interventions in collaboration with 7 other European societies have been published, which extensively referring to the latest randomized clinical trials, explicitly recommend percutaneous PFO closure in the prevention of recurrent thromboembolic events. In connection with the above facts and expecting incr...
Source: Polish Heart Journal - November 12, 2019 Category: Cardiology Authors: Araszkiewicz A, Bartuś S, Demkow M, Grygier M, Huczek Z, Komar M, Pracoń R, Przewłocki T, Sabiniewicz R, Smolka G, Olszowska M, Wojakowski W Tags: Kardiol Pol Source Type: research